Speakers Bureau

Faculty willing to give educational talks in Boston and surrounding communities about prevention, brain health, warning signs for Alzheimer’s disease and opportunities for clinical trials.

Rebecca E. Amariglio, Ph.D.

Clinical Neuropsychologist

Biography: Rebecca Amariglio is a clinical neuropsychologist at Brigham and Women’s Hospital and the Massachusetts General Hospital and Assistant Professor in Neurology at Harvard Medical School. Her work focuses on using sensitive subjective and objective cognitive tools in the early detection of Alzheimer’s disease. After completing her doctoral degree at the University of New Mexico, she trained as an intern at Yale School of Medicine and as a post-doctoral fellow at Brigham and Women’s Hospital and Massachusetts General Hospital. She is a recipient of the New Investigator Research Grant by the Alzheimer’s Association and the NIH Mentored Patient-Oriented Research Career Development Award.

Steven E. Arnold, M.D.

Translational Neurology Head of the Interdisciplinary Brain Center at Massachusetts General Hospital, Harvard Medical School.  

Biography: Dr. Steven E. Arnold is Translational Neurology Head of the Interdisciplinary Brain Center at Massachusetts General Hospital, Harvard Medical School.  

After receiving his M.D. from Boston University, Dr. Arnold completed residency training in Psychiatry at the New York State Psychiatric Institute / Columbia Presbyterian Medical Center in New York and residency training in Neurology at the University of Iowa Hospitals and Clinics in Iowa City. He also completed fellowship training in Behavioral Neurology / Cognitive Neuroscience and was a post-doctoral associate in Neuroanatomy in Iowa. Dr. Arnold is board certified in both neurology and psychiatry. After his training, Dr. Arnold joined the faculty at the University of Pennsylvania where he was Professor of Psychiatry and Neurology until his move to Massachusetts General Hospital in 2015. At Penn, he was Director of the Penn Memory Center, Associate Director and Clinical Core Leader of the Alzheimer’s Disease Core Center, Director of the Geriatric Psychiatry Section in the Department of Psychiatry, Director of the Cellular and Molecular Neuropathology Program in Psychiatry, and Associate Director of the University of Pennsylvania’s Institute on Aging. 

Dr. Arnold has conducted longstanding research on neurodegenerative disease pathology and molecular biomarkers in relation to cognitive decline and psychiatric syndromes in late life and has led broad clinical and translational research programs. He has authored over 250 scientific articles, reviews and chapters. Specific scientific interests include biomarkers for clinical trials in aging and dementias, metabolic and vascular risk factors for dementia and protective factors that account for cognitive resilience in aging. 

Jasmeer Chhatwal, M.D., Ph.D., MMSc

Attending physician and scientist in the MGH Department of Neurology, and an instructor in neurology at Harvard Medical School.  

Biography: Jasmeer Chhatwal is a research-oriented neurologist who is fascinated by the complex neurobiology that underlies human memory and the manner in which advanced age and neurodegenerative disease both diminish our capacity to form memories and recall information. He studied biology and philosophy at Yale University, neuroscience and medicine at Emory University, and clinical investigation at Harvard Medical School. Dr. Chhatwal has been based at Massachusetts General and Brigham and Women’s Hospitals since 2009, when he started as a resident in Adult Neurology. He is now an attending physician and scientist in the MGH Department of Neurology, and an instructor in neurology at Harvard Medical School. 

Dr. Chhatwal’s central interest is to deepen our understanding of how neurodegenerative diseases degrade cognitive neural networks and to apply this knowledge to help patients with memory disorders. His current research uses multi-modal neuroimaging (PET, functional and structural MRI), pharmacology, and genetics to better understand what differentiates individuals aging normally from those early on the pathway to neuro degeneration and severe cognitive decline.  He has a particular interest in genetic susceptibility to Alzheimer’s disease, and serves as the MGH/BWH site leader for the Dominantly Inherited Alzheimer’s Network (please see www.dian-info.org for more information).

Seth A. Gale, M.D.

Associate Neurologist, Brigham and Women’s Hospital, Instructor in Neurology, Harvard Medical School Study Physician and Investigate at CART 

Biography: Seth Gale, MD is a behavioral neurologist at Brigham and Women's Hospital, with interests in a broad spectrum of cognitive/behavioral disorders. His clinical focus is in the degenerative dementias, including Alzheimer disease and frontotemporal lobar degeneration (FTLD).  Dr. Gale has research interests in the organization and practice of behavioral neurology as a neurologic sub-specialty, the optimization of dementia clinical care, and “office-based” cognitive assessment in clinical practice.   At CART, Dr. Gale works as an investigator in multiple studies along the spectrum of Alzheimer disease. Dr. Gale graduated from the Medical College of Virginia at VCU, completed a neurology residency at Tufts Medical Center, and a Behavioral Neurology and Neuropsychiatry Fellowship at Brigham and Women’s Hospital.  

Jennifer R. Gatchel, M.D., Ph.D.

Assistant Psychiatrist in the Division of Geriatric Psychiatry at McLean Hospital and Massachusetts General Hospital and an Instructor of Psychiatry at Harvard Medical School

Biography: Jennifer R. Gatchel is an Assistant Psychiatrist in the Division of Geriatric Psychiatry at McLean Hospital and Massachusetts General Hospital and an Instructor of Psychiatry at Harvard Medical School (HMS).  She studied at The University of Texas-Austin, where she obtained a B.S. in Molecular Biology and a B.A. in honor liberal arts in 1999, and went on to earn a M.D. and Ph.D in Neuroscience at Baylor College of Medicine.  She completed her residency in adult psychiatry in the Massachusetts General Hospital/McLean Hospital residency program, followed by the Partners Healthcare Geriatric Psychiatry Clinical Fellowship Program.  She is a board certified psychiatrist.

Dr. Gatchel served as a chief resident and received the Thomas P. Hackett Award during her final year of residency. Stemming from her doctoral work on neurodegeneration, her clinical and research interests lie at the interface of mood and cognitive decline in aging. She has over eight years experience investigating mechanisms of brain-behavior relationships, which has led to publications, presentations, and Travel Fellowships (Society for Biological Psychiatry, American College of Neuropsychopharmacology, American Association of Geriatric Psychiatry).

Dr. Gatchel is a former P.R.I.T.E. Fellow and was recognized as an Honors Scholar (American Association of Geriatric Psychiatry) and Webb Fellow (Academy of Psychosomatic Medicine), and is the recipient of the 2016 American Association of Geriatric Psychiatry Member in Training Research Award. She is the recipient of the HMS Psychiatry Dupont Warren Fellowship and Livingston Award to carry out research investigating the neurobiology of depression in late life and early Alzheimer’s disease. She serves in leadership roles in resident geriatric psychiatry education.

Bernard Hanseeuw, M.D., Ph.D.

Behavioral Neurologist

Additional Languages Spoken: French, English, Spanish, Dutch

Biography: Bernard Hanseeuw is a behavioral neurologist. He obtained his MD, PhD in Belgium before moving to Boston. Since September 2014, he works as a postdoctoral research fellow at Massachusetts General Hospital. His research intends to understand the relationships between brain pathologies and cognitive deficits in normal aging and age-related disease, with a special focus on early detection of Alzheimer's disease. He has a special interest in brain imaging, particularly in amyloid, tau, and other PET imaging techniques. He aims to offer better care to patients with or at-risk for memory decline, and help the search of a cure, to keep longer the most precious gift we all have: our brain.

Bradley T. Hyman, M.D., Ph.D

Director, Massachusetts Alzheimer's Disease Research Center & John B. Penney Jr. Professor of Neurology, Harvard Medical School

Biography: Brad Hyman is the John B. Penny, Jr. Professor of Neurology at Harvard Medical School. He directs the Alzheimer’s unit at Mass General Institute for Neurological Disease (MIND), with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. Dr. Hyman’s laboratory studies the anatomical and molecular basis of dementia in Alzheimer’s disease and dementia with Lewy bodies.

Dr. Hyman received his M.D. and Ph.D. from University of Iowa, and he has received the Metropolitan Life Award, the Potamkin Prize, an NIH Merit award, and an Alzheimer’s Association Pioneer Award. He is the current director of the Massachusetts Alzheimer’s Disease Research Center. 

Jonathan Jackson, Ph.D.

Instructor in Neurology, Harvard Medical School, Departments of Neurology at Massachusetts General Hospital and Brigham & Women’s Hospital.

Biography: Jonathan Jackson, PhD, is a cognitive neuroscientist on faculty at Harvard Medical School, investigating the early detection of Alzheimer’s disease (AD), particularly in the absence of overt memory problems. He also serves Massachusetts General Hospital’s Alzheimer’s Disease Research Center (ADRC) and MGH’s Cancer Center Equity Program, specializing in identifying and overcoming barriers to clinical research for people and communities of color. His research focuses on midlife and late-life health disparities in clinical settings that affect Black populations, relevant to both dementia and oncology research.

Aaron Koenig, M.D.

Physician Investigator, Department of Neurology, Massachusetts General Hospital & Instructor in Neurology, Harvard Medical School

Biography: Dr. Koenig completed his pre-medical studies at Columbia University, and received his medical degree from the University of Pennsylvania in 2010. He completed his general psychiatry residency at Western Psychiatric Institute & Clinic in Pittsburgh in 2014, and served as a Chief Resident for Research during his final year of training. Dr. Koenig returned to the University of Pennsylvania in 2014 to complete a fellowship in Geriatric Psychiatry, and joined the staff of Massachusetts General Hospital in 2015 as an Assistant in Research. Dr. Koenig’s research focuses on the design and implementation of early-stage clinical trials to investigate medications for the prevention and treatment of Alzheimer’s Disease.

Gad Asher Marshall. M.D.

Associate Medical Director of Clinical Trials, Center for Alzheimer's Research and Treatment, Brigham and Women's Hospital & Assistant Professor of Neurology, Harvard Medical School

Biography: Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. Dr. Marshall has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 2, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with PiB and FDG PET, structural and resting-state functional MRI, and CSF biomarkers across the early Alzheimer’s disease spectrum.

Pages